| Medicamen Biotech Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 531146 |
NSE Symbol : MEDICAMEQ |
P/E(TTM) : 55.26 |
|
ISIN Demat : INE646B01010 |
Div & Yield% : 0.26 |
EPS(TTM) : 6.46 |
|
Book Value(₹) : 200.58 |
Market Cap(₹Cr) : 484.12 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 42.23 | 38.45 | 26.00 | 41.14 | 42.84 | 41.48 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 42.23 | 38.45 | 26.00 | 41.14 | 42.84 | 41.48 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.37 | 0.47 | 5.22 | 0.14 | 0.29 | 0.58 |
| Total Income | 42.60 | 38.92 | 31.21 | 41.28 | 43.13 | 42.06 |
| Total Expenditure | 37.21 | 34.41 | 27.09 | 34.90 | 36.30 | 36.62 |
| PBIDT | 5.39 | 4.50 | 4.13 | 6.38 | 6.84 | 5.44 |
| Interest | 0.81 | 0.56 | 0.62 | 0.73 | 1.01 | 0.68 |
| PBDT | 4.58 | 3.94 | 3.50 | 5.65 | 5.83 | 4.76 |
| Depreciation | 1.81 | 1.77 | 0.48 | 2.17 | 2.57 | 1.74 |
| Tax | 0.68 | 0.57 | 0.73 | 1.03 | 1.05 | 0.84 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.12 | -0.04 | -0.10 | -0.07 | -0.07 | -0.08 |
| Reported Profit After Tax | 2.21 | 1.64 | 2.40 | 2.52 | 2.27 | 2.26 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 2.21 | 1.64 | 2.40 | 2.52 | 2.27 | 2.26 |
| EPS (Unit Curr.) | 1.63 | 1.21 | 1.90 | 1.98 | 1.78 | 1.78 |
| EPS (Adj) (Unit Curr.) | 1.63 | 1.21 | 1.90 | 1.98 | 1.78 | 1.78 |
| Calculated EPS (Unit Curr.) | 1.63 | 1.21 | 1.89 | 1.98 | 1.78 | 1.78 |
| Calculated EPS (Adj) (Unit Curr.) | 1.63 | 1.21 | 1.89 | 1.98 | 1.78 | 1.78 |
| Calculated EPS (Ann.) (Unit Curr.) | 6.50 | 4.83 | 7.54 | 7.94 | 7.14 | 7.10 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 6.50 | 4.83 | 7.54 | 7.94 | 7.14 | 7.10 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 13.56 | 13.56 | 12.71 | 12.71 | 12.71 | 12.71 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 12.76 | 11.70 | 15.88 | 15.51 | 15.97 | 13.11 |
| PBDTM(%) | 10.85 | 10.25 | 13.46 | 13.73 | 13.61 | 11.48 |
| PATM(%) | 5.23 | 4.27 | 9.23 | 6.13 | 5.30 | 5.45 |